Live feed16:32:40·65dINSIDERFilingvia QuantisnowChief Commercial Officer Kalofonos Isabel was granted 34,000 shares, increasing direct ownership by 4,077% to 34,834 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CRNX· Crinetics Pharmaceuticals Inc.Health CareOriginal source
